Cepharanthine and Chemotherapy for IND-Enabling Esophageal Cancer Shows Positive Results
https://unsplash.com/photos/_jbClosDsD4

Cepharanthine and Chemotherapy for IND-Enabling Esophageal Cancer Shows Positive Results

According to a recent article, PharmaDrug Inc. revealed that their study of combining cepharanthine and chemotherapy to treat IND-enabling esophageal cancer has yielded positive results. Esophageal Cancer Esophageal cancer occurs…

Continue Reading Cepharanthine and Chemotherapy for IND-Enabling Esophageal Cancer Shows Positive Results

AI Could Predict Glaucoma Vision Loss

There is no doubt that artificial intelligence (AI) is going to change the future of healthcare. AI can be used in disease prediction, treatment, identification, diagnosis, and management. For example,…

Continue Reading AI Could Predict Glaucoma Vision Loss

Sjögren’s Syndrome Now Considered 2nd Most Common Autoimmune Condition

This year, the Congress of Clinical Rheumatology East took place from May 12-15, 2022. During the conference, clinical rheumatologists gathered to discuss trends in rheumatology, practice guidelines, and cutting-edge therapeutics.…

Continue Reading Sjögren’s Syndrome Now Considered 2nd Most Common Autoimmune Condition